triamterene has been researched along with 10-propargyl-10-deazaaminopterin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carmona-Martínez, V; García-Peñarrubia, P; Guirado, A; Martínez-Esparza, M; Ruiz-Alcaraz, AJ; Vera, M | 1 |
2 review(s) available for triamterene and 10-propargyl-10-deazaaminopterin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapeutic potential of pteridine derivatives: A comprehensive review.
Topics: Aminopterin; Animals; Anti-Infective Agents; Antidepressive Agents; Antihypertensive Agents; Antineoplastic Agents; Antiparasitic Agents; Clinical Trials as Topic; Humans; Inhibitory Concentration 50; Methotrexate; Pteridines; Triamterene | 2019 |